14 results on '"RAIMONDI, C."'
Search Results
2. Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I–II)
3. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
4. Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero
5. Detecting the disappearance of RAS-mutant clones in the plasma of patients with RAS-mutant mCRC to select patient candidates for anti-EGFR treatment and to monitor resistance to treatment
6. Second line EGFR-inhibitors in RAS mutant metastatic colorectal cancer: The plasma RAS wild type “window of opportunity”
7. Access of the oncologic patients to the emergency room of the local hospital during the three-year period 2014–2016
8. ctDNA might expand therapeutic options for second line treatment of KRAS mutant mCRC
9. Treatment in advanced malignant pleural mesothelioma after chemotherapy standard
10. 549P - Second line EGFR-inhibitors in RAS mutant metastatic colorectal cancer: The plasma RAS wild type “window of opportunity”
11. T23 - Access of the oncologic patients to the emergency room of the local hospital during the three-year period 2014–2016
12. 1672P - ctDNA might expand therapeutic options for second line treatment of KRAS mutant mCRC
13. A40 - Treatment in advanced malignant pleural mesothelioma after chemotherapy standard
14. P-141 - Detecting the disappearance of RAS-mutant clones in the plasma of patients with RAS-mutant mCRC to select patient candidates for anti-EGFR treatment and to monitor resistance to treatment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.